[Cardiovascular action of dipyridamole in advanced pregnancy (author's transl)].
Quantitative sphygmometry was used to check the cardiovascular action of an intravenous injection of 30 mg of dipyridamole in ten women, between the 31st and 38th weeks of pregnancy. Circulation was intact in all of them, but there was suspicion of intra-uterine foetal retardation. Moderate decline in arterial mean blood pressure was paralleled over a short period of time by increase in heart rate, stroke volume, and cardiac output. Overall peripheral resistance dropped with significance and caused, with some probability, increase in uterine perfusion. Hence, dipyridamole proved suitable for intra-uterine reanimation.
D000328:Adult; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D005317:Fetal Growth Retardation / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D010927:Placental Insufficiency / Q000188:drug therapy; D011247:Pregnancy; D011263:Pregnancy Trimester, Third
D004176:Dipyridamole
Kardiovaskuläre Wirkung von Dipyridamol in der Spätschwangerschaft.